麦角酰二乙胺治疗的并发症。
Complications of therapy with lysergide.
作者信息
Denson R
出版信息
Can Med Assoc J. 1969 Nov 29;101(11):53-7.
Abstract
All known complications which occurred during and after LSD treatment of 237 psychiatric patients on an open ward of a general hospital are described and classified. The results imply that clinical research with lysergide can be carried out in similar settings with relative safety.
摘要
描述并分类了在一家综合医院开放病房对237名精神科患者进行麦角酸二乙酰胺（LSD）治疗期间及之后出现的所有已知并发症。结果表明，在类似环境中进行麦角酰二乙胺的临床研究相对安全。
相似文献
1
Complications of therapy with lysergide.麦角酰二乙胺治疗的并发症。
Can Med Assoc J. 1969 Nov 29;101(11):53-7.
2
Lysergide therapy and the mauve factor.
Acta Psychiatr Scand. 1968;44(3):280-8. doi: 10.1111/j.1600-0447.1968.tb07514.x.
3
Lysergic acid diethylamide.
N Engl J Med. 1968 Feb 22;278(8):435-8. doi: 10.1056/NEJM196802222780806.
4
[Indications for the use of neuleptil. Review of the literature and clinical contribution].
Riv Sper Freniatr Med Leg Alien Ment. 1967;91:Suppl 5:1307+.
5
LSD psychotherapy: a review of the literature and some proposals for future research.
R I Med J. 1972 Sep;55(9):282-6.
6
A controlled study of LSD treatment in alcoholism and neurosis.一项关于LSD治疗酗酒和神经症的对照研究。
Br J Psychiatry. 1970 Apr;116(533):443-5. doi: 10.1192/bjp.116.533.443.
7
LSD and psychiatric inpatients.麦角酸二乙酰胺与精神病住院患者
Arch Gen Psychiatry. 1967 May;16(5):554-9. doi: 10.1001/archpsyc.1967.01730230038005.
8
The experimental use of psychedelic (LSD) psychotherapy.迷幻剂（麦角酸二乙酰胺）心理疗法的实验性应用。
Int Z Klin Pharmakol Ther Toxikol. 1971 Jun;4(4):446-54.
9
Dissociative delirium after treatment with lysergide.麦角酰二乙胺治疗后出现的分离性谵妄。
Can Med Assoc J. 1967 Nov 11;97(20):1222-4.
10
THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY.麦角酸二乙酰胺（LSD）在心理治疗中的应用。
Can Med Assoc J. 1964 Dec 5;91(23):1200-2.
引用本文的文献
1
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.经典致幻剂研究中的不良事件：系统评价与荟萃分析
JAMA Psychiatry. 2024 Dec 1;81(12):1225-1235. doi: 10.1001/jamapsychiatry.2024.2546.
2
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.经典致幻剂与自杀倾向之间的关系：一项系统综述
ACS Pharmacol Transl Sci. 2021 Mar 11;4(2):436-451. doi: 10.1021/acsptsci.1c00024. eCollection 2021 Apr 9.
本文引用的文献
1
Chromosome Damage Not Found in Leukocytes of Children Treated with LSD-25.在接受麦角酰二乙胺（LSD-25）治疗的儿童白细胞中未发现染色体损伤。
Science. 1968 Feb 16;159(3816):749. doi: 10.1126/science.159.3816.749.
2
HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.致幻剂。研究工具还是治疗药物。
Tex State J Med. 1963 Sep;59:848-52.
3
Use of d-lysergic acid diethylamide in the treatment of alcoholism.
Q J Stud Alcohol. 1959 Sep;20:577-90.
4
Adverse reactions during hospitalization.住院期间的不良反应。
Can Med Assoc J. 1967 Dec 9;97(24):1445-50.
5
Dissociative delirium after treatment with lysergide.麦角酰二乙胺治疗后出现的分离性谵妄。
Can Med Assoc J. 1967 Nov 11;97(20):1222-4.
6
LSD-25 and genetic damage.麦角酸二乙酰胺（LSD-25）与基因损伤
Dis Nerv Syst. 1969 Jan;30(1):42-6.
7
Unfavourable reactions to LSD: a review and analysis of the available case reports.麦角酸二乙酰胺（LSD）的不良反应：对现有病例报告的综述与分析
Can Med Assoc J. 1967 Nov 11;97(20):1214-21.
8
Lysergic-acid-diethylamide and cannabis as possible teratogens in man.麦角酸二乙酰胺和大麻可能是人类致畸物。
Lancet. 1968 Nov 16;2(7577):1087. doi: 10.1016/s0140-6736(68)91569-9.
9
Is lysergide a teratogen?麦角酰二乙胺是一种致畸剂吗？
Lancet. 1968 Mar 23;1(7543):639-40.
10
Is lysergic-acid diethylamide a teratogen?麦角酸二乙酰胺是一种致畸剂吗？
Lancet. 1967 Nov 18;2(7525):1066-8. doi: 10.1016/s0140-6736(67)90339-x.
Zotero 插件